Charles River Laboratories International Inc (CRL)

Industry Diagnostics & Research

This stock can be held in an Investment Account

Sell

$179.74

Buy

$180.47

arrow-up$15.615 (+9.49%)

Prices updated at 28 May 2026, 18:33 EDT

Prices minimum 15 mins delay

Prices in USD

Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.

S&P 500

0.53%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	4,050m	4,015m
	1,332m	1,323m
	442m	401m
	10.92	9.99
	10m	-144m
	581m	411m
Sales, General and administrative	751m	743m
Interest expenses	126m	107m
Provision for income taxes	68m	43m
Operating expenses	889m	922m
Income before taxes	93m	-100m
Net income available to common shareholders	10m	-144m
	0.2	-2.91
Net interest income	-118m	-102m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.2	-2.91
Free cash flow per share	10.8587	10.8209
Book value/share	73.9577	69.1925
Debt equity ratio	0.78694	0.81223

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	1,403m	1,447m
Current liabilities	994m	1,120m
Total capital	5,702m	5,276m
Total debt	2,724m	2,570m
Total equity	3,462m	3,165m
Total non current liabilities	-	-
Loans	2,240m	2,112m
Total assets	7,528m	7,135m
Total liabilities	-	-
Cash and cash equivalents	195m	214m
Common stock	51m	49m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	284m	206m
Cash dividends paid	-	-
	502m	518m
Investments (gains) losses	-245m	-209m
	206m	216m
Net income	-	-
	735m	738m
	-233m	-219m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.